Data will be updated when it becomes available.
Data will be updated when it becomes available.
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
Following IIFL’s January 2023 recommendation downgrade on Dr. Reddy’s Labs (Dr. Reddy’s), analysts at IIFL Securities have further cut their rating to Reduce (from Add). The stock’s 15% rally YTD seems to be out of sync with continued muted trends on the base business (ex-Revlimid).
Strong show expected
Healthy performance likely on a year-on-year basis
According to Dr Reddy's Laboratories Ltd, Life Insurance Corporation of India raised its ownership in the pharmaceutical company by purchasing 33.86 lakh shares, bringing its interest to 7.7%.
Single digit growth likely in key metrics versus the year-ago quarter
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.